Error in Study Linking HIV Resistance Gene to Increased Mortality
Emily Makowski | Sep 30, 2019
The authors have requested a retraction of a paper that found people with the CCR5 Δ32 variant are more likely to die sooner.
ccr5 delta32 genetic mutation hiv t cell
Genetic Mutation that Prevents HIV Infection Tied to Earlier Death
Emma Yasinski | Jun 3, 2019
Those with two copies of the Δ32 allele in the CCR5 gene are 21 percent more likely to die by age 76, although it’s not clear why.
Opinion: How Biomedicine Could Transform Human Reproduction
Henry T. Greely | Aug 1, 2021
CRISPR and other innovations are likely to open up a wealth of new options for how people have children.
Hong Kong skyline with a pink sky in the background
Book excerpt from CRISPR People
Henry T. Greely | Aug 1, 2021
In Chapter 6, author Henry T. Greely describes how news of the birth of gene-edited babies rocked a 2018 summit on human genome editing.
Resistance to HIV Engineered Via CRISPR
Anna Azvolinsky | Aug 3, 2017
Mice transplanted with human hematopoietic stem cells that have an HIV receptor gene, CCR5, disrupted by gene editing allows the animals to ward off HIV infection. 
Portrait of an HIV Conspirator
Ed Yong | Sep 12, 2013
The three-dimensional structure of CCR5, a protein which HIV uses to infect humans' cells, could lead to better anti-HIV drugs.
timothy ray brown ccr5 delta32 aids hiv activist
Timothy Ray Brown, First Person to Be Cured of HIV, Dies
Kerry Grens | Sep 30, 2020
The AIDS activist, also known as the Berlin patient, represented optimism that scientists could find a way to beat HIV.
The Scientist Staff | Aug 16, 1998
ASSAY ACE: Aaron Diamond's Alexandra Trkola helped develop an assay that characterized the binding mechanisms of the CCR5 coreceptor, which HIV uses, along with CD4, to gain initial entry into cells. A. Trkola, T. Dragic, J. Arthos, J.M. Binley, W.C. Olson, G.P. Allaway, C. ChengMayer, J. Robinson, P.J. Maddon, J.P. Moore, "CD4-dependent, antibody- sensitive interactions between HIV-1 and its co-receptor CCR-5," Nature, 384:184-7, 1996. (Cited in more than 165 papers since publication) Commen
The Best Offense?
Simon Frantz | Sep 1, 2007
The Best Offense? CCR5 inhibitors, moving toward market, suggest it may be a good defense By Simon Frantz Related Articles 5 HIV Treatment Strategies A piggyback attack: Using the common cold to deliver an HIV vaccine Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV Solving the viral spike: Can structural biology find a chink in HIV's armor? Reconstructing early HIV: The search for immunogen
Obituary, retrovirus, HIV, AIDS, virology, molecular virology, NCI, UCSD, Flossie Wong-Staal
Pioneering Molecular Virologist Flossie Wong-Staal Dies
Amanda Heidt | Jul 14, 2020
The University of California, San Diego, researcher helped identify the HIV retrovirus responsible for AIDS and developed treatments still in use today.

Refine your Search

Search Again